REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

G.D. Pharmaceuticals Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: G.D. Pharmaceuticals Pvt Ltd Profile Updated: June 26, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

G.D. Pharmaceuticals Pvt Ltd is a Private Limited Unlisted company incorporated on 01/04/1955 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is U24231WB1955PTC022265 and registration number is 022265. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
94, Nalini Ranjan Avenue, Kolkata Wb 700053 In
Kolkata; West Bengal;

Contact Details: Purchase the G.D. Pharmaceuticals Pvt Ltd report to view the information.

Basic Information
Outstanding Shares:
Purchase the G.D. Pharmaceuticals Pvt Ltd report to view the information.
Registered Capital:
Purchase the G.D. Pharmaceuticals Pvt Ltd report to view the information.
Incorporation Date:
April 01, 1955
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after G.D. Pharmaceuticals Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-3.72%▼
Total operating revenue
-3.01%▼
Operating profit (EBIT)
-4.8%▼
EBITDA
-4.63%▼
Net Profit (Loss) for the Period
-5.15%▼
Total assets
15.73%▲
Total equity
18.26%▲
Operating Profit Margin (ROS)
-0.49%▼
Net Profit Margin
-0.49%▼
Return on Equity (ROE)
-5.04%▼
Quick Ratio
0.31%▲
Cash Ratio
-2.23%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo